Charity depression recovery centre gets public list referrals
supplied
Wellington's unfunded depression recovery centre
Whakamātūtū
relies on donations but is being asked to take on patients from the public list.
The community programme offers therapeutic six week and four week day programmes for people with moderate to severe mental health needs.
It was established almost 18 months ago and offers a wrap-around programme - with a GP, psychiatrist, psychotherapists, a trauma treatment specialist as well as art, music and massage therapy.
It has backing from private health insurers and some referrals from ACC - but otherwise no public funding.
Whakamātūtū Director Martin Quinn says the programme helps what he calls the "missing middle" who suffer in silence, and says despite mostly being funded from donations, it is getting referrals from Health NZ's secondary mental health services.
He speaks with Susie Ferguson, along with board chair and former Retirement Commissioner, Dame Diana Crossan.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

RNZ News
an hour ago
- RNZ News
Samoan family seeks answers into son's death
Pacific health 19 minutes ago The parents of Caleb Moefa'auo are hoping the inquest into his death will bring changes into how individuals with mental disorders are treated while on remand.

RNZ News
2 hours ago
- RNZ News
Artificial intelligence saves doctors time, but makes mistakes
AI comes with the risk that younger doctors will not develop their critical-thinking skills. Photo: Doctors using artificial intelligence tools to take patient notes say it can make critical mistakes, but saves time. The University of Otago surveyed nearly 200 health professionals and found 40 percent used AI for patient notes, but there were problems with accuracy, legal and ethical oversight, data security, patient consent and the impact on the doctor-patient relationship. Bio-ethicist professor Angela Ballantyne lead the research and said nearly three-quarters of the doctors who used the tools found them helpful. Benefits included saving time - between 30 minutes and two hours a day - and improving rapport with patients by not having to take notes as they're talking. "On the other hand, people who had negative experiences said often the notes that were produced were too long, sometimes they include errors or hallucinations, and that sometimes it was quite subtle to pick up where those errors had popped in," Ballantyne said. "They thought sometimes it didn't capture the essence, like what was really important in the consultation, and sometimes it missed critical findings." Ballantyne was concerned doctors would become too reliant on the tools and warned the use of AI came with the risk that younger general practitioners not developing their critical-thinking skills. "I think that's a bit deceptive to refer to them as administrative tools," she said. "Actually, the process of writing a clinical note is... a cognitive process and requires critical thinking. "The clinician's greatest tool is their brain and it's the thinking that we want from clinicians, so I think we need to just track how they're being used." While AI was relatively new, doctors would check and edit the notes thoroughly, but Ballantyne worried that would lapse, as they got used to it. She also called for guidance and regulation around patient consent and the type of software used. About two-thirds of those surveyed had read the software terms and conditions, and about 60 percent sought patient consent. "When we were doing the research in 2024, it was a little bit of a wild west and, really, GPs being out on their own," Ballantyne said. Health NZ had endorsed two AI clinical scribe tools - Heidi Health and iMedX - and guidance around consent was expected from the Medical Council later this year. AI was unlikely to go away, so greater regulation was vital, she said. "Health providers are time poor and overburdened at the moment, and this does have the potential to be really helpful. "The things we want to see are more centralised regulatory and governance support, so that GPs aren't having to kind of pick and choose between tools themselves." Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.


Otago Daily Times
2 hours ago
- Otago Daily Times
Concerns raised over AI scribe tools for doctors
Major concerns have been raised about the security of private patient information in New Zealand after new research found 40% of the doctors surveyed are using AI scribes to take patient notes. Lead researcher and University of Otago (Wellington) primary healthcare and general practice bioethicist Professor Angela Ballantyne said AI was being rapidly taken up by primary care practices to transcribe patient notes during consultations, despite ongoing challenges with their legal and ethical oversight, data security, patient consent, and the impact on the doctor-patient relationship. "Most AI-scribes rely on international cloud-based platforms — often privately owned and controlled — for processing and storing data, which raises questions about where data is stored, who has access to it, and how it can be protected from cyber threats. "There are also Aotearoa-specific data governance issues that need to be recognised and resolved — particularly around Māori data sovereignty." Prof Ballantyne said 197 health providers working in primary care were surveyed in February and March 2024, providing a snapshot in time of the use of AI-scribes in clinical practice. Most of the respondents were GPs, but others included nurses, nurse practitioners, rural emergency care providers and practice managers. Of those surveyed, 40% reported using AI-scribes to take patient notes. Only 66% had read the terms and conditions on the use of the software, and 59% reported seeking patient consent, she said. Most of those surveyed who used AI scribes found them helpful, and 47% estimated it saved them between 30 minutes and two hours a day by using it in every consultation. However, "a significant minority" said the software did not save time overall because it took so long to edit and correct AI-generated notes, she said. "[Doctors] need to be vigilant about checking patient notes for accuracy. "However, as many survey respondents noted, carefully checking each AI-generated clinical note eats into, and sometimes negates any time savings." Many had concerns about the accuracy, completeness and conciseness of the patient notes produced by AI-scribes, and some were concerned about its inability to understand New Zealand accents or vocabulary and te reo Māori. Others using an AI scribe felt it enabled them to focus more on their patients and build better engagement and rapport through more eye contact and active listening. But there was concern among those surveyed about whether the use of an AI-scribe complied with New Zealand's ethical and legal frameworks. Prof Ballantyne said it could not be assumed that patients consented to their use. "Patients should be given the right to opt out of the use of AI and still access care, and adequate training and guidelines must be put in place for health providers." In July, the National Artificial Intelligence and Algorithm Expert Advisory Group at Health New Zealand Te Whatu Ora endorsed two ambient AI scribe tools — Heidi Health and iMedX, for use by its clinicians in New Zealand. Prof Ballantyne said the Medical Council of New Zealand was expected to release guidance about the use of AI in health later this year, which was likely to require patients to give consent to the use of AI transcription tools. And there was still a need to track and evaluate the impact of AI tools on clinical practice and patient interactions, she said.